Company Number: 12527213

Analysis Date: 2025-07-29 14:04 UTC

Financial Health Assessment of DEKTRANS LTD as at 31 March 2024

---

1. Financial Health Score: D

Explanation:
DEKTRANS LTD exhibits symptoms of financial distress with a very low net asset base (£100) and sharply declining cash reserves (£884) compared to prior years. The company's working capital is barely positive (£100), indicating a fragile liquidity position. While the company remains solvent, these vital signs suggest caution as it struggles to maintain operational cash flow and equity cushion.

---

2. Key Vital Signs:

Metric	2024 Value	Interpretation
Cash at bank	£884	Critically low cash reserves show tight liquidity; "healthy cash flow" is lacking.
Current Liabilities	£784	Short-term debts are close to cash on hand, leaving minimal margin for operational needs.
Net Current Assets	£100	Very narrow positive working capital; "symptom of stress" indicating limited buffer.
Net Assets (Equity)	£100	Extremely low shareholders’ funds, down from £6,488 in 2022, signaling erosion of financial health.
Share Capital	£100	Nominal capital base; no sign of recent capital injections to strengthen balance sheet.
Average Employees	2	Micro-sized operation; limited scale may restrict revenue growth potential.
Filing Status	Up to date	Compliance with filings is good; no overdue accounts or penalties detected.

---

3. Diagnosis:

DEKTRANS LTD is like a patient whose vital organs are functioning but showing severe depletion of reserves. The company’s cash levels and net assets have steadily declined over the last two years—from £6,488 in net assets in 2022 to just £100 in 2024. This sharp deterioration is a clear "symptom of distress," possibly due to ongoing losses, inadequate profitability, or operational challenges in the freight transport sector.

The extremely thin working capital margin means the company has very little financial flexibility to absorb shocks such as delayed payments or unexpected expenses. Although there is no indication of insolvency or immediate liquidity crisis (current liabilities are currently covered by cash), the financial health is precarious.

The company’s micro size and limited equity base restrict its ability to raise funds via equity markets or bank lending, potentially hampering growth or investment in business improvements.

---

4. Recommendations:

• Improve Cash Flow Management: Prioritize accelerating receivables collection and negotiating longer payment terms with suppliers to build a healthier cash buffer. Consider short-term financing options if needed to prevent cash flow squeeze.

• Enhance Profitability: Conduct a detailed cost analysis to identify and cut unnecessary expenses. Explore opportunities to increase revenues through improved service offerings or new client acquisition.

• Capital Injection: Consider bringing in additional equity or shareholder loans to strengthen the balance sheet and improve net asset position, providing a cushion against future uncertainties.

• Regular Financial Monitoring: Implement monthly financial reviews focusing on liquidity ratios and cash forecasts to catch early warning signs and react promptly.

• Strategic Review: Given the specialized freight transport market, evaluate competitive positioning and potential for operational efficiencies or partnerships to bolster margins.

• Maintain Compliance: Continue timely filing of accounts and returns to avoid penalties and maintain good standing with Companies House.

---

Medical Analogy Summary:
DEKTRANS LTD currently suffers from "financial malnutrition" with depleted reserves and minimal liquidity—akin to a patient with a weakened immune system. Without intervention, the risk of "financial shock" increases. However, with targeted "treatment" such as cash flow management and capital support, recovery is possible.

---